155 related articles for article (PubMed ID: 38401507)
1. CT-guided high dose rate brachytherapy can induce multiple systemic proteins of proliferation and angiogenesis predicting outcome in HCC.
Salvermoser L; Goldberg SN; Alunni-Fabbroni M; Kazmierczak PM; Gröper MN; Schäfer JN; Öcal E; Burkard T; Corradini S; Ben Khaled N; Petrera A; Wildgruber M; Ricke J; Stechele M
Transl Oncol; 2024 May; 43():101919. PubMed ID: 38401507
[TBL] [Abstract][Full Text] [Related]
2. Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy.
Stechele M; Link H; Hirner-Eppeneder H; Alunni-Fabbroni M; Wildgruber M; Salvermoser L; Corradini S; Schinner R; Ben Khaled N; Rössler D; Galun E; Goldberg SN; Ricke J; Kazmierczak PM
Radiat Oncol; 2023 Jul; 18(1):125. PubMed ID: 37507808
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MRI (DWI) for assessment of response to high-dose-rate CT-guided brachytherapy (HDR-BT) of hepatocellular carcinoma.
Karim H; Thormann M; Omari J; Surov A; Schinner R; Seidensticker R; Ingenerf M; Ricke J; Schmid-Tannwald C
Acta Radiol; 2024 Jan; 65(1):14-22. PubMed ID: 36843430
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of CT-guided HDR brachytherapy as a local ablative treatment for renal masses: a single-arm pilot trial.
Damm R; Streitparth T; Hass P; Seidensticker M; Heinze C; Powerski M; Wendler JJ; Liehr UB; Mohnike K; Pech M; Ricke J
Strahlenther Onkol; 2019 Nov; 195(11):982-990. PubMed ID: 31346674
[TBL] [Abstract][Full Text] [Related]
5. Dosimetry of local failure with single dose 19 Gy high-dose-rate brachytherapy for prostate cancer.
Armstrong S; Tsang Y; Lowe G; Tharmalingam H; Alonzi R; Ostler P; Hughes R; Hoskin P
Radiother Oncol; 2021 Apr; 157():93-98. PubMed ID: 33493500
[TBL] [Abstract][Full Text] [Related]
6. CT-guided High-Dose-Rate Brachytherapy versus Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma.
Auer TA; Müller L; Schulze D; Anhamm M; Bettinger D; Steinle V; Haubold J; Zopfs D; Pinto Dos Santos D; Eisenblätter M; Gebauer B; Kloeckner R; Collettini F
Radiology; 2024 Feb; 310(2):e232044. PubMed ID: 38319166
[TBL] [Abstract][Full Text] [Related]
7. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929
[TBL] [Abstract][Full Text] [Related]
8. High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes.
le Guyader M; Lam Cham Kee D; Thamphya B; Schiappa R; Gautier M; Chand-Fouche ME; Hannoun-Levi JM
Clin Transl Radiat Oncol; 2022 Jan; 32():15-23. PubMed ID: 34816022
[TBL] [Abstract][Full Text] [Related]
9. 3D-image-guided HDR-brachytherapy versus 2D HDR - brachytherapy after external beam radiotherapy for early T-stage nasopharyngeal carcinoma.
Ren Y; Zhao Q; Liu H; Huang Y; Wang Z; Cao X; Teh BS; Wen B
BMC Cancer; 2014 Nov; 14():894. PubMed ID: 25432818
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Protumorigenic Effects after Image-Guided Radiofrequency Ablation of Hepatocellular Carcinoma Using Biomarkers.
Stechele M; Wildgruber M; Markezana A; Kästle S; Öcal E; Kimm MA; Alunni-Fabbroni M; Paldor M; Haixing L; Salvermoser L; Pech M; Powerski M; Galun E; Ricke J; Goldberg SN
J Vasc Interv Radiol; 2023 Sep; 34(9):1528-1537.e1. PubMed ID: 36442741
[TBL] [Abstract][Full Text] [Related]
11. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S
Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
[TBL] [Abstract][Full Text] [Related]
12. Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma.
Walter F; Nierer L; Rottler M; Duque AS; Weingandt H; Well J; Shpani R; Landry G; Seidensticker M; Streitparth F; Ricke J; Belka C; Corradini S
Radiat Oncol; 2021 May; 16(1):86. PubMed ID: 33957941
[TBL] [Abstract][Full Text] [Related]
13. The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition.
Pellizzon AC; Salvajoli J; Novaes P; Maia M; Fogaroli R; Gides D; Horriot R
Int J Med Sci; 2008 Jun; 5(3):113-20. PubMed ID: 18566673
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer.
Dhere VR; Fischer-Valuck BW; Goyal S; Liu Y; Morgan TM; Ghavidel E; Moghanaki DM; Hershatter BW; Patel PR; Jani AB; Godette KD; Rossi PJ; Patel SA
Brachytherapy; 2021; 20(6):1130-1138. PubMed ID: 34417136
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of computed tomography-guided
He C; Liu Y; Li Y; Yang L; Li YT; Li SL; Huang XQ
J Cancer Res Ther; 2018; 14(4):754-759. PubMed ID: 29970648
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intrahepatic progression patterns of hepatocellular carcinoma and colorectal liver metastases following CT-guided high dose-rate brachytherapy.
Xu H; Schmidt R; Hamm CA; Schobert IT; He Y; Böning G; Jonczyk M; Hamm B; Gebauer B; Savic LJ
Ther Adv Med Oncol; 2021; 13():17588359211042304. PubMed ID: 34539817
[TBL] [Abstract][Full Text] [Related]
17. Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort.
Wedde TB; Småstuen MC; Brabrand S; Fosså SD; Kaasa S; Tafjord G; Russnes KM; Hellebust TP; Lilleby W
Radiother Oncol; 2019 Mar; 132():211-217. PubMed ID: 30389241
[TBL] [Abstract][Full Text] [Related]
18. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
[TBL] [Abstract][Full Text] [Related]
19. Definitive high-dose-rate endobronchial brachytherapy of bronchial stump for lung cancer after surgery.
Skowronek J; Piorunek T; Kanikowski M; Chicheł A; Bielęda G
Brachytherapy; 2013; 12(6):560-6. PubMed ID: 23850277
[TBL] [Abstract][Full Text] [Related]
20. Comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix.
Kamran SC; Manuel MM; Cho LP; Damato AL; Schmidt EJ; Tempany C; Cormack RA; Viswanathan AN
Gynecol Oncol; 2017 May; 145(2):284-290. PubMed ID: 28318644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
